APA aipamena

Gu, H., Zhou, R., Ni, J., Xu, X., Cheng, X., Li, Y., & Chen, X. (2020). The value of secondary neoadjuvant chemotherapy in platinum-sensitive recurrent ovarian cancer: A case-control study post GOG-0213 trial. J Ovarian Res.

Chicago Style aipamena

Gu, Hongyuan, Rui Zhou, Jing Ni, Xia Xu, Xianzhong Cheng, Yan Li, and Xiaoxiang Chen. "The Value of Secondary Neoadjuvant Chemotherapy in Platinum-sensitive Recurrent Ovarian Cancer: A Case-control Study Post GOG-0213 Trial." J Ovarian Res 2020.

MLA aipamena

Gu, Hongyuan, et al. "The Value of Secondary Neoadjuvant Chemotherapy in Platinum-sensitive Recurrent Ovarian Cancer: A Case-control Study Post GOG-0213 Trial." J Ovarian Res 2020.

Kontuz: berrikusi erreferentzia hauek erabili aurretik.